Wharton jelly mesenchymal stem cells (DrugBank: -)
1 disease| 告示番号 | 疾患名（ページ内リンク） | 臨床試験数 |
|---|---|---|
| 97 | 潰瘍性大腸炎 | 1 |
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT03299413 (ClinicalTrials.gov) | June 5, 2017 | 27/9/2017 | Use of Mesenchymal Stem Cells in Inflammatory Bowel Disease | Ulcerative Colitis Stem Cell Therapy | Inflammatory Bowel Diseases | Biological: Wharton Jelly Mesenchymal stem cells | Hanan Jafar | Scientific Research Support fund | Active, not recruiting | 18 Years | 75 Years | All | 20 | Phase 1;Phase 2 | Jordan |